Sees strong double digit worldwide Cardiac Ablation Solutions growth in Q3. Says expects surgical to return to more normalized growth in in Q3. Says expects sequential gross margin improvements in Q3 and Q4. Says on track to deliver high-single-digit reported EPS growth in second half. Comments and guidance taken from Q2 earnings conference call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Options Volatility and Implied Earnings Moves Today, November 19, 2024
- Medtronic raises FY25 adjusted EPS view to $5.44-$5.50 from $5.42-$5.50
- Medtronic reports Q2 EPS $1.26, consensus $1.25
- Notable companies reporting before tomorrow’s open
- Options Volatility and Implied Earnings Moves This Week, November 18 – November 21, 2024